RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain

Detalles Bibliográficos
Autores principales: Zou, Denise, Niyazov, Alexander, Arondekar, Bhakti, Wu, Sherry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714493/
https://www.ncbi.nlm.nih.gov/pubmed/34657754
http://dx.doi.org/10.1016/j.breast.2021.10.003
_version_ 1784623922197561344
author Zou, Denise
Niyazov, Alexander
Arondekar, Bhakti
Wu, Sherry
author_facet Zou, Denise
Niyazov, Alexander
Arondekar, Bhakti
Wu, Sherry
author_sort Zou, Denise
collection PubMed
description
format Online
Article
Text
id pubmed-8714493
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87144932022-01-05 RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain Zou, Denise Niyazov, Alexander Arondekar, Bhakti Wu, Sherry Breast Letter to the Editor Elsevier 2021-10-13 /pmc/articles/PMC8714493/ /pubmed/34657754 http://dx.doi.org/10.1016/j.breast.2021.10.003 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Zou, Denise
Niyazov, Alexander
Arondekar, Bhakti
Wu, Sherry
RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
title RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
title_full RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
title_fullStr RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
title_full_unstemmed RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
title_short RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
title_sort re: cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in spain
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714493/
https://www.ncbi.nlm.nih.gov/pubmed/34657754
http://dx.doi.org/10.1016/j.breast.2021.10.003
work_keys_str_mv AT zoudenise recostutilityoftalazoparibmonotherapytreatmentforlocallyadvancedormetastaticbreastcancerinspain
AT niyazovalexander recostutilityoftalazoparibmonotherapytreatmentforlocallyadvancedormetastaticbreastcancerinspain
AT arondekarbhakti recostutilityoftalazoparibmonotherapytreatmentforlocallyadvancedormetastaticbreastcancerinspain
AT wusherry recostutilityoftalazoparibmonotherapytreatmentforlocallyadvancedormetastaticbreastcancerinspain

Ejemplares similares